Yu CJ - Search Results

1

Final Overall Survival and Other Efficacy and Safety Results From ASCEND-3: Phase II Study of Ceritinib in ALKi-Naive Patients With ALK-Rearranged NSCLC.

Nishio M, Felip E, Orlov S, Park K, Yu CJ, Tsai CM, Cobo M, McKeage M, Su WC, Mok T, Scagliotti GV, Spigel DR, Viraswami-Appanna K, Chen Z, Passos VQ, Shaw AT. Nishio M, et al. Among authors: yu cj. J Thorac Oncol. 2020 Apr;15(4):609-617. doi: 10.1016/j.jtho.2019.11.006. Epub 2019 Nov 25. J Thorac Oncol. 2020. PMID: 31778798 Free article. Clinical Trial.

2

High dose tamoxifen plus cisplatin and etoposide in the treatment of patients with advanced, inoperable nonsmall cell lung carcinoma.

Yang CH, Cheng AL, Yeh KH, Yu CJ, Lin JF, Yang PC. Yang CH, et al. Among authors: yu cj. Cancer. 1999 Aug 1;86(3):415-20. doi: 10.1002/(sici)1097-0142(19990801)86:3<415::aid-cncr9>3.0.co;2-h. Cancer. 1999. PMID: 10430249 Clinical Trial.

3

Epidermal growth factor receptor mutations in needle biopsy/aspiration samples predict response to gefitinib therapy and survival of patients with advanced nonsmall cell lung cancer.

Shih JY, Gow CH, Yu CJ, Yang CH, Chang YL, Tsai MF, Hsu YC, Chen KY, Su WP, Yang PC. Shih JY, et al. Among authors: yu cj. Int J Cancer. 2006 Feb 15;118(4):963-9. doi: 10.1002/ijc.21458. Int J Cancer. 2006. PMID: 16152581 Free article.

4

Survival outcome and predictors of gefitinib antitumor activity in East Asian chemonaive patients with advanced nonsmall cell lung cancer.

Yang CH, Shih JY, Chen KC, Yu CJ, Yang TY, Lin CP, Su WP, Gow CH, Hsu C, Chang GC, Yang PC. Yang CH, et al. Among authors: yu cj. Cancer. 2006 Oct 15;107(8):1873-82. doi: 10.1002/cncr.22220. Cancer. 2006. PMID: 16989002 Free article.

5

Revisit of 1997 TNM staging system--survival analysis of 1112 lung cancer patients in Taiwan.

Perng RP, Chen CY, Chang GC, Hsia TC, Hsu NY, Tsai YH, Tsai CM, Yang CH, Chen YM, Yu CJ, Lee JJ, Hsu HS, Yu CT, Kao EL, Chiu CH. Perng RP, et al. Among authors: yu cj, yu ct. Jpn J Clin Oncol. 2007 Jan;37(1):9-15. doi: 10.1093/jjco/hyl119. Epub 2006 Dec 1. Jpn J Clin Oncol. 2007. PMID: 17142253

6

A phase II study of oral vinorelbine in combination with cisplatin conducted in Taiwan in patients with unresectable localized or metastatic non-small cell lung carcinoma.

Chen YM, Yu CJ, Yang CH, Perng RP, Tsai CM, Shih JF, Cheng AL, Lefresne F, Barbier M, Pouget JC, Yang PC. Chen YM, et al. Among authors: yu cj. Lung Cancer. 2007 Apr;56(1):89-95. doi: 10.1016/j.lungcan.2006.11.017. Epub 2007 Jan 8. Lung Cancer. 2007. PMID: 17208330 Clinical Trial.

7

Predictive factors of gefitinib antitumor activity in East Asian advanced non-small cell lung cancer patients.

Chang GC, Tsai CM, Chen KC, Yu CJ, Shih JY, Yang TY, Lin CP, Hsu JY, Chiu CH, Perng RP, Yang PC, Yang CH. Chang GC, et al. Among authors: yu cj. J Thorac Oncol. 2006 Jul;1(6):520-5. J Thorac Oncol. 2006. PMID: 17409911 Free article.

8

Outcome of advanced nonsmall cell lung cancer patients receiving gemcitabine and weekly paclitaxel as first-line treatment.

Lin ZZ, Hsu C, Chang YC, Yu CJ, Hsu CH, Lin CC, Cheng AL, Yang PC, Yang CH. Lin ZZ, et al. Among authors: yu cj. Lung Cancer. 2008 May;60(2):215-21. doi: 10.1016/j.lungcan.2007.10.002. Epub 2007 Nov 19. Lung Cancer. 2008. PMID: 18022277 Clinical Trial.

9

Radiotherapy in lung adenocarcinoma with brain metastases: effects of activating epidermal growth factor receptor mutations on clinical response.

Gow CH, Chien CR, Chang YL, Chiu YH, Kuo SH, Shih JY, Chang YC, Yu CJ, Yang CH, Yang PC. Gow CH, et al. Among authors: yu cj. Clin Cancer Res. 2008 Jan 1;14(1):162-8. doi: 10.1158/1078-0432.CCR-07-1468. Clin Cancer Res. 2008. PMID: 18172267

10

High efficacy of erlotinib in Taiwanese NSCLC patients in an expanded access program study previously treated with chemotherapy.

Perng RP, Yang CH, Chen YM, Chang GC, Lin MC, Hsieh RK, Chu NM, Lai RS, Su WC, Tsao CJ, Hsia TC, Chen HC, Chen CH, Huang MS, Wang JL, Ho ML, Chung CY, Yu CJ, Chang WC, Kuo HP, Yu CT, Lin ZZ, Kao WY. Perng RP, et al. Among authors: yu cj, yu ct. Lung Cancer. 2008 Oct;62(1):78-84. doi: 10.1016/j.lungcan.2008.02.023. Epub 2008 Apr 18. Lung Cancer. 2008. PMID: 18423781 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,025 results

Search Page